In partnership with the Dermatology Education Foundation, view featured articles from Dermatology Times with expert NP and PA commentary.

Derm NP and PA Resource Center

August clinical considerations for NPs and PAsIn this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
June Clinical Considerations for NPs, PAsThis month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
May Clinical Considerations for NPs, PAsThis month, we take a look at a treatment approach to hidradenitis suppurativa, the impact of atopic dermatitis on pediatric patients and a way to prevent mycosis fungoides progression.
April Clinical Considerations for NP's, PAsIn this month's Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval.
March Clinical Considerations for NPs, PAsThis month we’re looking at some allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulaters.
February Clinical Considerations for NPs, PasIn our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
January Clinical Considerations for NPs, PAsThis month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology.
How the Trump presidency may impact dermatologyDermatology’s leaders share perspectives on how the new Administration may impact medicine.
December Clinical Considerations for NPs, PAsIn this month's Clinical Considerations, we take a look at AD and bullying, whether or not derms are doing enough for psoriasis patients, and the potential of Epicutaneous immunotherapy.
Pearls to optimize safety, success with biologicsOne dermatologist describes his considerations for choosing a biologic to treat a patient with moderate-to-severe psoriasis, baseline assessments, and follow-up approach.